Athanasopoulos Takis, Foster Helen, Foster Keith, Dickson George
Institute of Biomedical and Life Sciences, South West London Academic Network, St. George's University of London, London, UK.
Methods Mol Biol. 2011;709:21-37. doi: 10.1007/978-1-61737-982-6_2.
Duchenne muscular dystrophy (DMD) is a severe muscle wasting X-linked genetic disease caused by dystrophin gene mutations. Gene replacement therapy aims to transfer a functional full-length dystrophin cDNA or a quasi micro/mini-gene into the muscle. A number of AAV vectors carrying microdystrophin genes have been tested in the mdx model of DMD. Further modification/optimization of these microgene vectors may improve the therapeutic potency. In this chapter, we describe a species-specific, codon optimization protocol to improve microdystrophin gene therapy in the mdx model.
杜兴氏肌营养不良症(DMD)是一种由肌营养不良蛋白基因突变引起的严重肌肉萎缩性X连锁遗传病。基因替代疗法旨在将功能性全长肌营养不良蛋白cDNA或准微/小基因导入肌肉。一些携带微肌营养不良蛋白基因的腺相关病毒(AAV)载体已在DMD的mdx模型中进行了测试。对这些微基因载体进行进一步的修饰/优化可能会提高治疗效果。在本章中,我们描述了一种物种特异性的密码子优化方案,以改善mdx模型中的微肌营养不良蛋白基因治疗。